Activity of Hybrid Type I Interferons in Cells Lacking Tyk2: A Common Region of IFN-α8 Induces a Response, but IFN-α2/8 Hybrids Can Behave Like IFN-β

Journal of Interferon and Cytokine Research

Volumn 23, Issue 11, 2003, Pages 655-666

  Platis, Dimitris ^a   Foster, Graham R ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR ANTIBODY; ALPHA2 INTERFERON; ALPHA8 INTERFERON; BETA INTERFERON; HYBRID PROTEIN; INTERFERON; PROTEIN KINASE; PROTEIN TYK2; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR MIMICRY; MUTANT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANTIBODIES; CELLS, CULTURED; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN HYBRIDIZATION; PROTEIN-TYROSINE KINASES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TYK2 KINASE;

EID: 0344010945     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003322558791     Document Type: Article

References (40)

1. DE MAEYER, E., and MAEYER-GUIGNARD, J. (1998) Type I interferons. Int. Rev. Immunol. 17, 53-73.
2. PESTKA, S., LANGER, J.A., ZOON, K.C., and SAMUEL, C.E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
3. DIAZ, M.O., BOHLANDER, S., and ALLEN, G. (1993). Nomenclature of human interferon genes. J. Interferon Res. 13, 243-244.
4. FOSTER, G.R., RODRIGUES, O., GHOUZE, F. SCHULTE-FROHLINDE, E., TESTA, D., LIAO, M.J., STARK, G.R., LEADBEATER, L., and THOMAS, M.C. (1996). Different relative activities of human cell-derived interferon-α subtypes: IFN-α 8 has very high antiviral potency. J. Interferon Cytokine Res. 16, 1027-1033.
5. FOSTER, G.R., and FINTER, N.B. (1998). Are all type I human interferons equivalent? J. Viral Hepatitis 5, 143-152.
6. RHODES, J., IVANYI, J., and COZENS, P. (1986). Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin-1 production by using recombinant interferons and corticosteroids. Eur. J. Immunol. 16, 370-375.
7. HIBBERT, L., and FOSTER, G.R. (1999). Human type I interferons differ greatly in their effects on the proliferation of primary B cells. J. Interferon Cytokine Res. 19, 309-318.
8. ORTALDO, J.R., HERBERMAN, R.B., HARVEY, C., OSHEROFF, P., PAN, Y.C., KELDER, B., and PESTKA, S. (1984). A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc. Natl. Acad. Sci. U.S.A 81, 4926-4929.
9. KARPUSAS, M., NOLTE, M., BENTON, C.B., MEIER, W., LIPSCOMB, W.N., and GOELZ, S. (1997). The crystal structure of human interferon beta at 2.2-A resolution. Proc. Natl. Acad. Sci. USA 94, 11813-11818.
10. RADHAKRISHNAN, R., WALTER, L.J., HRUZA, A., REICHERT, P., TROTTA, P.P., NAGABHUSHAN, T.L., and WALTER, M.R. (1996). Zinc-mediated dimer of human interferon-alpha 2b revealed by x-ray crystallography. Structure 4, 1453-1463.
11. SENDA, T., SHIMAZU, T., MATSUDA, S., KAWANO, G., SHIMIZU, H., NAKAMURA, K.T., and MITSUI, Y. (1992). Three-dimensional crystal structure of recombinant murine interferon-beta. EMBO J. 11, 3193-3201.
12. KLAUS, W., GSELL, B., LABHARDT, A.M., WIPF, B., and SENN, H. (1997). The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution. J. Mol. Biol. 274, 661-675.
13. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400.
14. UZE, G., LUTFALLA, G., and GRESSER, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
15. COHEN, B., NOVICK, D., BARAK, S., and RUBINSTEIN, M. (1995). Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15, 4208-4214.
16. FISH, E.N. (1992). Definition of receptor binding domains in interferon-alpha. J. Interferon Res. 12, 257-266.
17. MITSUI, Y., and SENDA, T. (1997). Elucidation of the basic three-dimensional structure of type I interferons and its functional and evolutionary implications. J. Interferon Cytokine Res. 17, 319-326.
18. UZE, G., DI MARCO, S., MOUCHEL-VIELH, E., MONNERON, D., BANDU, M.T., HORISBERGER, M.A., DORQUES, A., LUTFALLA, G., and MOGENSEN, K.E. (1994). Domains of interaction between alpha interferon and its receptor components. J. Mol. Biol. 243, 245-257.
19. DARNELL, J.E., JR., KERR, I.M., and STARK, G.R. (1994). Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
20. PLATANIAS, L.C., and FISH, E.N. Signaling pathways activated by interferons. Exp. Hematol. 27, 1583-1592.
21. DA SILVA, A.J., BRICKELMAIER, M., MAJEAU, G.R., LUKASHIN, A.V., PEYMAN, J., WHITTY, A., and HOCHMAN, P.S. (2002). Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α2b vs. IFN-β1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22, 173-188.
22. DOMANSKI, P., NADEAU, O.W., PLATANIAS, L.C., FISH, E., KELLUM, M., PITHA, P., and COLAMONICI, O.R. (1998). Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J. Biol. Chem. 273, 3144-3147.
23. PLATANIAS, L.C., UDDIN, S., and COLAMONICI, O.R. (1994). Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J. Biol. Chem. 269, 17761-17764.
24. PLATANIAS, L.C., UDDIN, S., DOMANSKI, P., and COLAMONICI, O.R. (1996). Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J. Biol. Chem. 271, 23630-23633.
25. LU, J., CHUNTHARAPAI, A., BECK, J., BASS, S., OW, A., DE VOS, A.M., GIBBS, V., and KIM, K.J. (1998). Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2. J. Immunol. 160, 1782-1788.
26. NOVICK, D., NABIOULLIN, R.R., RAGSDALE, W., McKENNA, S., WEISER, W., GARONE, L., BURKINS, C., KIM, S.H., RUBINSTEIN, M., TEPPER, M.A., and ARULANANDAM, A.R. (2000). The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation. J. Interferon Cytokine Res. 20, 971-982.
27. LEWERENZ, M., MOGENSEN, K.E., and UZE, G. (1998). Shared receptor components but distinct complexes for alpha and beta interferons. J. Mol. Biol. 282, 585-599.
28. GAUZZI, M.C., BARBIERI, G., RICHTER, M.F., UZE, G., LING, L., FELLOUS, M., and PELLEGRINI, S. (1997). The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor. Proc. Natl. Acad. Sci. USA 94, 11839-11844.
29. PELLEGRINI, S., JOHN, J., SHEARER, M., KERR, I.M., and STARK, G.R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
30. PLATIS, D., and FOSTER, G.R. (2002). High yield expression, refolding and characterisation of recombinant interferon alpha 2/alpha8 hybrids in Escherichia coli protein expression and purification. Protein Expr. Purif. 31, 222-230.
31. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
32. UZE, G., BANDU, M.T., EID, P., GRUTTER, M., and MOGENSEN, K.E. (1988). Electrostatic interactions in the cellular dynamics of the interferon-receptor complex. Eur. J. Biochem. 171, 683-691.
33. PIEHLER, J., and SCHREIBER, G. (1999). Mutational and structural analysis of the binding interface between type I interferons and their receptor IFNAR2. J. Mol. Biol. 294, 223-237.
34. PIEHLER, J., ROISMAN, L.C., and SCHREIBER, G. (2000). New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275, 40425-40433.
35. RUNKEL, L., PFEFFER, L., LEWERENZ, M., MONNERON, D., YANG, C.H., MURTI, A., PELLEGRINI, S., GOELZ, S., UZE, G., and MOGENSEN, K. (1998). Differences in activity between alpha and beta type I interferons explored by mutational analysis. J. Biol. Chem. 273, 8003-8008.
36. VELAZQUEZ, L., MOGENSEN, K.E., BARBIERI, G., FELLOUS, M., UZE, G., and PELLEGRINI, S. (1995). Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 270, 3327-3334.
37. PATTYN, E., VAN OSTADE, X., SCHAUVLIEGE, L., VERHEE, A., KALAI, M., VANDERKERCKHOVE, J., and TAVERNIER, J. (1999). Dimerization of the interferon type I receptor IFNAR2-2 is sufficient for induction of interferon effector genes but not for full antiviral activity. J. Biol. Chem. 274, 34838-34845.
38. RANI, M.R., FOSTER, G.R., LEUNG, S., LEAMAN, D., STARK, G.R., and RANSOHOFF, R.M. (1996). Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J. Biol. Chem. 271, 22878-22884.
39. RANI, M.R., GAUZZI, C., PELLEGRINI, S., FISH, E.N., WEI, T., and RANSOHOFF, R.M. (1999). Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2. J. Biol. Chem. 274, 1891-1897.
40. SETO, M.H., HARKINS, R.N., ADLER, M., WHITLOW, M., CHURCH, W.B., and CROZE, E. (1995). Homology model of human interferon-alpha 8 and its receptor complex. Protein Sci. 4, 655-670.